Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods
CLINICAL BIOCHEMISTRY, vol.38, no.6, pp.552-557, 2005 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 38 Issue: 6
- Publication Date: 2005
- Doi Number: 10.1016/j.clinbiochem.2005.02.011
- Journal Name: CLINICAL BIOCHEMISTRY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.552-557
- Keywords: tacrolimus, MEIA II, EMIT, hematocrit, anemia, RDW, LIVER-TRANSPLANT RECIPIENTS, MICROPARTICLE ENZYME-IMMUNOASSAY, RENAL-TRANSPLANTATION, HEPATIC-CLEARANCE, FK506, PHARMACOKINETICS, ASSAY, BINDING, KIDNEY, ELISA
- Akdeniz University Affiliated: Yes
Abstract
Objectives: Tacrolimus (FK506) is a potent immunosuppressive drug used for prevention of rejection following transplantation. Several methods including immunoassays have been used for monitoring tacrolimus levels. The purpose of the present study was to compare the effects of various hematological parameters on whole blood tacrolimus concentrations which were measured with two different analytical methods, namely the microparticle enzyme immunoassay (MEIA II) and enzyme multiplied immunoassay technique (EMIT).